Oncology Update Louis Lao. Objective How to cure cancer in the Asian population (20min)
Rudd final 20min sanfran wcbp 2012 - cdn.ymaws.comRudd, PM et al. Bioinformatics, 2011 Giorgio Carta...
Transcript of Rudd final 20min sanfran wcbp 2012 - cdn.ymaws.comRudd, PM et al. Bioinformatics, 2011 Giorgio Carta...
WCBP 2012O-linked glycansO-linked glycans
Pauline M RuddDublin-Oxford
Glycobiology groupy gy g p
Conway Institute
From Back – Eoin Cosgrave, Weston Struwe, Oscar Potter, Michael Schomburg, Patrick Jennings, Karina Marino, Jayne Telford, Niaobh McLoughlin, John O’Rourke, Barbara
Keegan, Ciara McManus, Mark Hilliard, Jayesh Kattla, Rebecca Duke, Barbara Adamczyk, R dk F h J WithRadka Fahey, Joanne Withers
Missing from group photograph - Eugene Dempsey, Margaret Doherty, Natalia Artemenko, Tharmala Tharmalingam, Marie Galligan, Giorgio Carta
Carbohydrate – Peptide linkages in Glycoproteins
NtAsn-X-Ser
N-GlycanGelatinase B
N-linked glycans
CXXGG(S/T)CO-fucose
Ser
O
ThrO-GalNAc
O-GalNAc
O-linked glycanSer/Pro/Thr/Ser domain
O fucose
Asn-X-Thr
N-Glycan
C
OGlycan
OOEtN O
PO
O-Inositol
AsnCXSXPC O-glucose
y Glycan O-Inositol
O O
P
OHuman
erythrocyte CD59 EPO
O
O
ON-linked glycan
tPAO OC CO-linked glycanGPI
anchor
tPA
Biosynthesis of O-glycans in Golgi
Specific transferases add initialmonosaccharide (GalNAc)
to Ser/Thr -OH groups accessible
Core I
on fully folded protein
Core II
Core III
Ser/Thr
Core IIIGalNAc
GalCore IV……. XII
Gal
GlcNAc
Sequential additions of monosaccharides by other transferases give branching, elongation and termination
Core 2
Major O-glycan core structures
Core 1 - Gal(β1,3)GalNAc Core 2 - Galβ1,3[GlcNAcβ1,6]GalNAc
Core 3 - GlcNAc(β1,3)GalNAc Core 4 - GlcNAcβ1,3[GlcNAcβ1,6]GalNAc
Symbolic notation- embedded monosaccharide sequence, linkage and anomericity
Linkage positionOpen symbols: hexoseFilled in: HexNAc
Antigenicity
Blood Group
4
86
GlcNAc
pAntigens
A
23
4Gal
GalNAcB
A
2
β li k
Linkage typeFuc (deoxy galactose)
B
β-linkage
α-linkageNeuNAc Ounknown
Functions for O-glycans
O-linked glycansprotect hinge
IgD: a secreted and gmembrane bound
glycoprotein
IgD forms part of the B-Cell Receptor antigen613/11/2003 06:44
IgD forms part of the B-Cell Receptor antigen capture mechanism on lymphocytes
O-linked glycans extend peptide linkers: CD8T cell
140 A80A
MHC ICD8αβ
APC
Lec3.2.8.1 CHO K1
s valuesP values (shape)
(size)1.614.08
1.543.30
Merry, Gilbert, Wormald, Dwek, Classen, Rudd, Davis J. Biol. Chem.
Recognition: sIgA binds pathogenic gut bacteria
Secretory component 7N-links
O-glycosylatedO-glycosylated
hinge regionO glycosylatedhinge region
hinge region
I AJ chainsIgA
sIgAJ-chainI N-link 4 N-links4N-links
Secretory IgA O-glycans 2AB2AB 2AB
2AB2AB
O-glycans2AB
2AB2AB2AB
2AB2AB2AB
2AB2AB
2AB
2AB 2AB2AB
2AB
2AB
2AB2AB
2AB
2AB2AB
2AB2AB2AB2AB
2AB2AB
2AB2AB
2AB2AB
2AB2AB2AB
2AB
2AB2AB 2AB 2AB
2AB2AB
2AB
2AB2AB2AB
Galβ1 3GlcNAc1 2 3 4 5 6 7 8 9 10GU
Galβ1-3GlcNAc
sIgA O-glycans bind bacteria
E.coliE.coli
Actinomyces Naeslundii
Helicobacter pylori
Effect of glycosyltransferase changes O l ion O-glycan processing
tumour cellscontrol cells
Core 2 Truncated
tumour cells
E t d d l
control cells
Core 2
α6ST1
Core 2β6GNT glycanExtended glycan Core 2
β6 GNT
α6ST1
SLex
Elongation of 1,6 GlcNAc arm -
Stop signal forβ3GalT
Premature termination on both arms -SialylTn antigen
expression of Lewis structures
Loss of Golgi organisation: may relate to pH changes and contribute to glycan changes in malignant cells or culture
cancerHealthy controll
Golgi apparatus di i d i lldisorganised in cancer cells
cancer associated carbohydrate Ag
High levelsAbsent / low
T, Tn, STn
Golgi pH6: normal pathwaycarbohydrate Ag
expression
High Golgi pH in tumour cells may: Ser/Thr T
• be a result of reduced proton pump activity
• be sub-optimal for glycosyltransferase activity
Ser/Thr
Ser/Thr
Tn
Sialyl Tn
• interfere with ER / Golgi recycling
KelloKumpu et al, FEBS (2002) 516; 217-224
Site occupancy: Overexpression of MUC-1 with increased O-glycosylation aids detachment in breast cancerglycosylation aids detachment in breast cancer
ubiquitous cell surface expression
MUC-1expression
increased sialylation MUC-1
O-glycan site occupancy doubled
ChallengesN il bl f i l f O li k d l• No enzymes available for generic release of O‐linked glycans– O‐glycosidase removes: Gal(β1‐3)GalNAc– But requires exoglycosidases to remove other sugars from core
NeuAc
– But requires exoglycosidases to remove other sugars from core
GalNAcβ1,3 Ser/Thr
NeuAc
Gal
O‐glycosidase
+Sialidase
• Chemical methods available• Hydrazine• Ammonia‐based β‐elimination
Ser/Thr
LC-MS: O-glycan Release ChemistryO-glycan Chemical Release:
O
OR1OH
R ORcX
Reductive β-elimination
R 2O
O O
NHRnH
-OH
AcNH Alditol
OHOR1
OH
R2OOH
NaBH4
Aldose
OOR1
OH
R2O
Fluorescent labelling not
iblH2O
2AcNH
O
OR1OH
RX
HO-
H2O
2O
O HAcNH possible
OHOR1OH
R2OO
H
R 2O
O O
Rc
NHRn
X
AcNH
Further
‘Peeling Product’
R O + H O+OH
OR1OH
-OH2 H
AcNH degradationHR2O- + H2O+
OO
AcNH
Non-reductive β-elimination
Total Area
Optimization of β-elimination release for Bovine Submaxillary Mucin O-glycans
20
β-Elimination Optimization with Bovine Submaxillary Mucin
2 4 6 8
6e+8
Total Area
0 1e+8 2e+8 3e+8
Submaxillary Mucin O glycans
10
12
14
16
18
% P
eele
d
10 12 14 16 18 20 3e+8
4e+8
5e+8
Area
(μV
*sec
)
3e 8 4e+8 5e+8 6e+8
2
4
6
8
15
20
25
30
6065
70
%
Time (
Hours)
0
1e+8
2e+8
10
15
20
25
30
5560
6570
A
Time (
Hours)
T10
4550
55Temperature ( oC)45
50Temperature ( oC)
Total % of Peaks 2-5 Total area unpeeled glycansPeeling: Blue: minimum Recovery: Red maximumPeeling: Blue: minimum Recovery: Red maximum
Tharmala Tharmalingam, Li Liu, Jodie Abrahams, Margaret Doherty, JonathanTharmala Tharmalingam, Li Liu, Jodie Abrahams, Margaret Doherty, Jonathan Bones, Niaobh McLoughlin
E l i f I bili iEvaluation of Immobilisation
Cervical Mucin
Optimised O-glycan releaseCervical Mucin
• Highly reproducible , robust basis for O‐glycan analysis
• Used for Mucins• Bovine Cervical
P i Il d C l• Porcine Ileum and Colon • Chicken mucins
Ammonium hydroxide saturated ith A i b t
3. Evaporate
Robotic compatible platform for O-glycan release and labelling
Glycoprotein sample
Wash
with Ammonium carbonate
2. Release glycans
ammonia
4. Salt cleanupCarbon filter to clean up salts
Incubate 65oC for 16
1. Dehydrated mucins
sample
Waste
Carbon filter to clean up saltshours
Dry5. Formic Acid Treatment1
6. 2AB fluorescent label
Fluo
rescen
ce 23 4
Compare GU values with
2AB
7.Elute 2AB‐
Fluo
rescen
ce
10 15 20 25 30 35 40 45 50 55 60 65Time (mins)
Glycobase
10. Structure Assignment
glycans 8.NPHPLC profile of glycan pool Transfer to SPE
plate
Time (mins)
cence
Dry, redissolve in set volume
9. Exoglycosidase digestions
Fluo
resc
Fluo
rescen
ce
Time (mins)
autoGU
Exoglycosidase Digestions: O-glycans Bovine cervical mucins
Preliminary assignments for bovine cervical mucinO-glycans - HPLC
Unicarb‐DB: Glycan LC‐MS Database
Glycan Structure
LC-MS DetailsLC MS Details
ReferencesBiological Information
Composition
Sequence Information
Possible Structural Isomershttp://unicarb-db.comp
Hayes C., Campbell, M., Struwe W., Karlsson, N., Rudd, PM et al. Bioinformatics, 2011
Giorgio CartaJohn O’Rourke
LC-MS: O-glycan Sample Prep WorkflowO-glycoprotein Purification
Glycan Release - Reductive β-elimination: 50 mM NaOH and 0.50 M NaBH4 at 50°C for 16 h
g y p
B t R l
Peptide Removal and Desalting:DOWEX AG-50 cation exchange resin on the top of a C18 Zip-tip (Millipore).
(resin was washed with 1 mL MeOH, primed with 1M HCl and equilibrated with 1 mL H2O)
Borate Removal: 5 washes of 60 μL 1% acetic acid in MeOH
glycan samples were reconstituted in 10 μL H2O prior to LC-MS analysis
LC MS A l iLC-MS AnalysisAnalysis of glycan alditols performed in negative mode using an ion trap mass spectrometer with an Agilent
1100 HPLC binary pump and HTC-PAL autosampler.HPLC analytical columns consisted of 5 μm porous graphatized carbon in a fused silica capillary (20 cm x 180
μm i d ; o d 375 μm) The solvent flow rate was between 8 12 μL per minuteμm i.d.; o.d. 375 μm). The solvent flow rate was between 8-12 μL per minute.
Structural Annotationglycan analysis was performed with the aid of the Unicarb-DB glycan database
(http://www unicarb db com)(http://www.unicarb-db.com)
Weston Struwe
Mucin O-glycans from Chicken Intestines
Analysis of chicken intestinal mucin O‐glycans:
C j j i i l b i• C. jejuni is a commensal bacteria in chickens
• Chicken mucin attenuated bacterial binding & is attributed tobacterial binding & is attributed to mucin glycosylation (Alemka et al.)
• Large intestine inhibited C. jejunibinding and internalization betterbinding and internalization better than small Intestine and caecum
• Goal: To Identify glycosylation differences in the chickendifferences in the chicken intestinal tract as it pertains to C. jejuni colonization
Chicken Mucins are Highly Sulphated and Sialylated OH
315 OH
OH
OH
NHAcOO
NHAcOH
O
OH
O
OH
OH
SO4-
OH
241
301315
OH
OH
444241 444 OH
OH
OH
NHAcOO
NHAcOH
O
O
OH
OH
OH
OH
SO4-
282
505
Mucin O-glycans are extended core III and core IV
• Large Intestine contains N-glycolylneuranimic acid
Mucin O glycans are extended core III and core IV• Large Intestine contains more glycan diversity• More charged structures in the LI
g g y y
• 18 structures present in Large Intestine
Sulphation is present throughout
8 st uctu es p ese t a ge test e• 13 structures present in Small Intestine• 13 structures present in Caecum
http://www.extension.org/pages/31093/campylobacter-jejuni
FDA Approved Glycoprotein Biomarkers
PROTEIN/MARKER CANCER TYPE
α-fetoprotein (AFP) gastric, liver, testicular
CA 125 (MUC16) gastric, lung, ovarian
CA 15.3 (MUC1) breast
CA 19 9 l t l t i li tiCA 19.9 colorectal, gastric, liver, pancreatic
Carcinoembryonic antigen (CEA) breast, colorectal, gastric, lung, pancreatic, thyroid
Complement factor H protein bladderComplement factor H protein bladder
Human chorionic gonadotropin-β testicularKallikrein 3 (prostate specific antigen, PSA) prostate
O-glycosylated therapeutucs
Follicle Stimulating Hormone)Prolactin endometrial carcinoma
Thyroglobulin thyroid
ErbB2 Her2/neu breast
Follicle Stimulating HormoneLuteinising HormoneVon Willebrand factor
Th id ti l ti hErbB2, Her2/neu breastThyroid stimulating hormone
Glycan analysis is complexThe question determines the technological approach
Marino Rudd et al Nature Chemical Biology 2010
Instrument Acquisitions Agilent TLAOscar Potter
Marino, Rudd et al Nature Chemical Biology 2010
Oscar Potter
Beckmann CEGiorgio Carta Glycobase
Key Personnel
Jonathan Bones
Mark Hilliard
StefanMittermayer
WestonStruwe
Margaret Docherty
Michael Schomberg
Andras Guttman group